🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condit...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2020-06-02
Trial ID
NCT03985423
Treatments Being Tested
In an ageing population, the need for interventions to help older people re...
Status
Completed
Location
Wageningen University
Start Date
2014-12
Trial ID
NCT02349282
Treatments Being Tested
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
The purpose of this study is to assess the effect of the coadministration o...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-05
Trial ID
NCT02234882
Treatments Being Tested
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
The aim of this study is to answer the questions below; 1. Is there a diff...
Status
Enrolling By Invitation
Location
Izmir Bozyaka Research and Training Hostpital
Start Date
2021-11-10
Trial ID
NCT05115461
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested
This study evaluates the safety and tolerability of the addition of immunos...
Status
Terminated
Location
NYU Cancer Institute
Start Date
2014-03
Trial ID
NCT02061449
Treatments Being Tested